
<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <title>Research</title>
    
    
    <link rel="stylesheet" href="assets/css/tipsy.css" />
    <script src="http://ajax.googleapis.com/ajax/libs/jquery/1/jquery.min.js"></script>
    
    <!-- bxSlider Javascript file -->
    <script src="/assets/js/jquery.bxslider.min.js"></script>
    <!-- bxSlider CSS file -->
    <link href="/assets/css/jquery.bxslider.css" rel="stylesheet" />
    
    <script src="assets/js/jquery.tipsy.js"></script>
   
    
    <meta name="author" content="Xiu Huang">

    <!-- Enable responsive viewport -->
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="http://html5shim.googlecode.com/svn/trunk/html5.js"></script>
    <![endif]-->

    <!-- Le styles -->
    <link href="/assets/themes//bootstrap/css/bootstrap.2.2.2.min.css" rel="stylesheet">
    <link href="/assets/themes//css/style.css?body=1" rel="stylesheet" type="text/css" media="all">

    <!-- Le fav and touch icons -->
  <!-- Update these with your own images
    <link rel="shortcut icon" href="images/favicon.ico">
    <link rel="apple-touch-icon" href="images/apple-touch-icon.png">
    <link rel="apple-touch-icon" sizes="72x72" href="images/apple-touch-icon-72x72.png">
    <link rel="apple-touch-icon" sizes="114x114" href="images/apple-touch-icon-114x114.png">
  -->

    <!-- atom & rss feed -->
    <link href="/atom.xml" type="application/atom+xml" rel="alternate" title="Sitewide ATOM Feed">
    <link href="/rss.xml" type="application/rss+xml" rel="alternate" title="Sitewide RSS Feed">

  </head>

  <body>
    <div class="navbar">
      <div class="navbar-inner">
        <div class="container-narrow">
          <a class="brand" href="/">Xiu Huang</a>
          <ul class="nav">
            
            
            


  
    
      
      	
      	<li><a href="/About%20me">About</a></li>
      	
      
    
  
    
      
      	
      	<li><a href="/Interests">Interests</a></li>
      	
      
    
  
    
      
      	
      	<li><a href="/Publication">Publication</a></li>
      	
      
    
  
    
      
      	
      	<li class="active"><a href="/Research" class="active">Research</a></li>
      	
      
    
  
    
      
      	
      	<li><a href="/archive">Blog</a></li>
      	
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  
    
      
    
  



          </ul>
        </div>
      </div>
    </div>

    <div class="container-narrow">

      <div class="content">
        
<div class="page-header">
  <h1>Research </h1>
</div>

<div class="row-fluid">
  <div class="span12">
    
<p>My main research interest is to apply statistical and computational methods to
analyze high dimensional biological data from cancer patients, the ultimate goal
of which is to identify new predictive or prognostic biomarkers to facilitate
the understanding of the underlying mechanisms of them.</p>

<p> </p>

<ul>
  <li>Pathway Analysis of Drug Effects on Gene Expression in Different Tissues for
Genetically Engineered Mice Carrying Colon Cancer:</li>
</ul>

<p><img src="assets/images/research1.png" alt="" /></p>

<pre><code>Figure1: Our proposed method IBPA identified more cancer related pathway level change in three relevant tissues compared with Gene Set Enrichment Analysis (GSEA).
</code></pre>

<p> </p>

<ul>
  <li>Survival Relevant Translational Signals in Tumor-adjacent-normal Tissues:</li>
</ul>

<p> </p>

<p><img src="assets/images/research2.png" alt="" /></p>

<pre><code>Figure 2: In different cancer cohorts in TCGA, adjacent normal tissues always provide complementary information towards survival prediction.
</code></pre>

<p> </p>

<ul>
  <li>Drug Effects on Somatic Mutation Profiles in Patients’ Circulating Tumor
DNAs:</li>
</ul>

<p><img src="assets/images/research3.png" alt="" /></p>

<pre><code>Figure 3: Our proposed somatic mutation calling method always gives the best ROC curve in terms of predicting the spiked-in mutation proportions (panel 1: 1%; panel 2: 0.5%; panel 3: 0.2%), simulating the real case of circulating tumor DNA samples from patients. 
</code></pre>

<p> </p>

  </div>
</div>


      </div>
      <hr>
      <footer>
        <p>&copy; 2016 Xiu Huang
        </p>
      </footer>

    </div>

    
  </body>
</html>

